Pepticom's New Spinout Company, PeptiCov, to Focus on COVID-19
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
JERUSALEM, March 10, 2021 /PRNewswire-AsiaNet/ -- Pepticom, a leader in artificial intelligence peptide drug design and discovery, announced today that it has raised $2.6 million to establish a company to focus on treatments for the SARS-Cov-2 virus, responsible for the COVID-19 outbreak. The...
Authors: LATEST ASIANET NEWS RELEASES